These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7487206)
1. Preoperative chemotherapy: where do we go from here? Eberlein TJ Ann Surg; 1995 Nov; 222(5):609-11. PubMed ID: 7487206 [No Abstract] [Full Text] [Related]
2. [Local recurrence in premenopausal women with breast cancer: risk factors and effect of therapy]. Sautter-Bihl ML; Hetzel-Sesterheim M Strahlenther Onkol; 2001 Jan; 177(1):52-3. PubMed ID: 11200115 [No Abstract] [Full Text] [Related]
3. Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: equivalent outcomes? Smith BL Ann Surg; 2013 Feb; 257(2):180-1. PubMed ID: 23291659 [No Abstract] [Full Text] [Related]
4. Surgical considerations in selecting local therapy. Margolese R J Natl Cancer Inst Monogr; 1992; (11):41-8. PubMed ID: 1627430 [TBL] [Abstract][Full Text] [Related]
5. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients. Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007 [TBL] [Abstract][Full Text] [Related]
7. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Veronesi U; Bonadonna G; Zurrida S; Galimberti V; Greco M; Brambilla C; Luini A; Andreola S; Rilke F; Raselli R Ann Surg; 1995 Nov; 222(5):612-8. PubMed ID: 7487207 [TBL] [Abstract][Full Text] [Related]
8. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Fisher B; Brown A; Mamounas E; Wieand S; Robidoux A; Margolese RG; Cruz AB; Fisher ER; Wickerham DL; Wolmark N; DeCillis A; Hoehn JL; Lees AW; Dimitrov NV J Clin Oncol; 1997 Jul; 15(7):2483-93. PubMed ID: 9215816 [TBL] [Abstract][Full Text] [Related]
9. [The role of neoadjuvant chemotherapy for breast cancer treatment]. Inaji H; Komoike Y; Motomura K; Kasugai T; Koyama H Gan To Kagaku Ryoho; 2002 Jul; 29(7):1113-9. PubMed ID: 12145989 [TBL] [Abstract][Full Text] [Related]
10. Preoperative chemotherapy for breast cancer: lessons learned and future prospects. Sledge GW J Clin Oncol; 2003 Dec; 21(24):4481-2. PubMed ID: 14625269 [No Abstract] [Full Text] [Related]
11. [Respective indications for hormone therapy, induction chemotherapy and adjuvant chemotherapy in breast cancer without clinically discernable distant metastases]. Roy JA; Piccart MJ Rev Med Brux; 1995; 16(4):242-4. PubMed ID: 7481234 [TBL] [Abstract][Full Text] [Related]
12. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not? Ragaz J; Spinelli JJ Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049 [No Abstract] [Full Text] [Related]
13. [Neoadjuvant (preoperative) chemotherapy in cancer of the breast]. Shparik IaV Klin Khir; 1996; (8):38-42. PubMed ID: 9064142 [No Abstract] [Full Text] [Related]
14. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678 [TBL] [Abstract][Full Text] [Related]
15. Preoperative chemotherapy and potential impact on re-excision for early breast cancer. Batsis H; Ignantiadou E; Harissis HV Ann Surg Oncol; 2009 Oct; 16(10):2956-7; author reply 2958-9. PubMed ID: 19575266 [No Abstract] [Full Text] [Related]
16. Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves? Marks LB; Prosnitz LR J Clin Oncol; 2014 Feb; 32(6):491-3. PubMed ID: 24378409 [No Abstract] [Full Text] [Related]
17. Preoperative chemotherapy and breast-conserving therapy: why not everyone? Recht A J Clin Oncol; 1997 Jul; 15(7):2479-82. PubMed ID: 9215815 [No Abstract] [Full Text] [Related]
18. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000. Cancer Control; 2001; 8(1):55. PubMed ID: 11176036 [No Abstract] [Full Text] [Related]
20. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients. Choi HK; Cho N; Moon WK; Im SA; Han W; Noh DY Eur J Radiol; 2012 Apr; 81(4):737-43. PubMed ID: 21300498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]